Skip to main content
High RiskFDAfda-F-0828-2020UNDECLARED ALLERGEN

Barts Ice Cream Co. brand of Chocolate Chip Cookie Dough ice cream (Vanilla ice cream with chunks of cookie dough and dark chocolate chip...

Category
Units Affected
1,064
Recall Date
February 27, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0828-2020.

Product mislabeled as "GF" for gluten-free; however, ingredient statement lists wheat flour as a sub ingredient.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0828-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Snow's Acquisition, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0828-2020.

Snow's Acquisition, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Snow's Acquisition, Llc Recall FAQ

Snow's Acquisition, Llc is the subject of a dairy safety report: Barts Ice Cream Co. brand of Chocolate Chip Cookie Dough ice cream (Vanilla ice cream with chunks of cookie dough and dark chocolate chip.... The notice was published on February 27, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 1,064 units are potentially affected.